-
Federal
Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France
U.S. Department of Health & Human Services —
The field of gene therapy for bone and joint disorders has grown considerably over the last two and a half years. Investigators have shown that ex vivo or in vivo... -
Federal
Immune ablation and stem-cell therapy in autoimmune disease: Experimental basis for autologous stem-cell transplantation
U.S. Department of Health & Human Services —
Treatment of rats suffering from florid chronic progressive systemic arthritis or from chronic remitting/relapsing encephalomyelitis with autologous bone marrow... -
Federal
Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease
U.S. Department of Health & Human Services —
There is mounting evidence for a role of the growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF) in inflammatory disease, including arthritis. In... -
Federal
Gene therapy in rheumatoid arthritis: how to target joint destruction?
U.S. Department of Health & Human Services —
Gene therapy in rheumatoid arthritis: how to target joint destruction?